BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 21, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: New research identifies EBV antigen targets for MS therapies
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science
BioWorld Science
RSS
Phase II trial of Xcytrin for recurrent low-grade NHL under way
June 18, 2004
Efaproxyn and Revaproxyn, new trade names for efaproxiral
June 18, 2004
Emisphere initiates new trial to select oral form of unfractionated heparin
June 18, 2004
OSI and Genentech sign new Tarceva agreements
June 18, 2004
Second phase III trial of phenserine for Alzheimer's disease
June 18, 2004
Sepracor resubmits Estorra NDA
June 18, 2004
FDA approves Rapinex powder for oral suspension 20 mg
June 18, 2004
Disappointing preliminary phase IIa results for NGD-2000-1 in RA
June 18, 2004
Clinical efficacy of a BAY-43-9006 combination regimen in advanced melanoma
June 18, 2004
Vasogen updates Celacade phase III program
June 18, 2004
Previous
1
2
…
12712
12713
12714
12715
12716
12717
12718
12719
12720
…
18131
18132
Next
RSS